These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34238342)

  • 1. Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial.
    Chen Y; Yu M; Liu Z; Zhang Y; Li Q; Yang G
    Trials; 2021 Jul; 22(1):437. PubMed ID: 34238342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Jiang Y; Liu LS; Shen LP; Liu JX; Jiang GN; Gu AQ; Li HC; Li Q; Li HG; Huang PX
    Clin Lung Cancer; 2019 Sep; 20(5):e541-e547. PubMed ID: 31230892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
    Yao J; Jiao L; Yao Y; Lu Y; Shi J; Li J; Chen P; Xu L; Gong Y
    Trials; 2020 Apr; 21(1):309. PubMed ID: 32245480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients.
    Xu L; Li H; Xu Z; Wang Z; Liu L; Tian J; Sun J; Zhou L; Yao Y; Jiao L; Su W; Guo H; Chen P; Liu J
    BMC Complement Altern Med; 2012 Aug; 12():112. PubMed ID: 22853619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial.
    Gao R; Zhang Y; Hou W; Li J; Zhu G; Zhang X; Xu B; Wu Z; Wang H
    Trials; 2021 Mar; 22(1):214. PubMed ID: 33731199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
    Deng C; Lou Y; Gao Y; Deng B; Su F; Jia L
    Trials; 2020 May; 21(1):370. PubMed ID: 32357899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol.
    Deng L; Shayan G; Jiang W; Bi N; Wang L
    Thorac Cancer; 2024 Apr; 15(11):938-943. PubMed ID: 38426233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.
    Chen W; Lin J; Yang T; Xin Zhang Z; Tao L; Xiao Z; Chen H; Qi X; Sun L; Cao Y; Lin L
    Integr Cancer Ther; 2023; 22():15347354221151147. PubMed ID: 36710490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial.
    Zhou ZY; Xu L; Li HG; Tian JH; Jiao LJ; You SF; Han ZF; Jiang Y; Guo HR; Liu H
    J Integr Med; 2014 May; 12(3):175-81. PubMed ID: 24861837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol.
    Asao T; Watanabe S; Tanaka T; Morita S; Kobayashi K
    BMC Cancer; 2022 Nov; 22(1):1135. PubMed ID: 36333680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chinese herbal medicine formula on progression-free survival among patients with metastatic colorectal cancer: Study protocol for a multi-center, double-blinded, randomized, placebo-controlled trial.
    Wang Q; Li Z; Guo J; Li W; You F
    PLoS One; 2022; 17(12):e0275058. PubMed ID: 36525406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial.
    Jiang Y; Liu LS; Shen LP; Han ZF; Jian H; Liu JX; Xu L; Li HG; Tian JH; Mao ZJ
    Complement Ther Med; 2016 Feb; 24():55-62. PubMed ID: 26860802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter randomized controlled trial to assess the efficacy of cancer green therapy in treatment of stage IIIb/IV non-small cell lung cancer.
    Sun M; Zhou T; Fang X; Wang D; Pang H; Chen Y; Hu K
    Medicine (Baltimore); 2020 Aug; 99(33):e21626. PubMed ID: 32872022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study.
    Rudin CM; Awad MM; Navarro A; Gottfried M; Peters S; Csőszi T; Cheema PK; Rodriguez-Abreu D; Wollner M; Yang JC; Mazieres J; Orlandi FJ; Luft A; Gümüş M; Kato T; Kalemkerian GP; Luo Y; Ebiana V; Pietanza MC; Kim HR;
    J Clin Oncol; 2020 Jul; 38(21):2369-2379. PubMed ID: 32468956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.
    Schenk EL; Mandrekar SJ; Dy GK; Aubry MC; Tan AD; Dakhil SR; Sachs BA; Nieva JJ; Bertino E; Lee Hann C; Schild SE; Wadsworth TW; Adjei AA; Molina JR
    J Thorac Oncol; 2020 Jan; 15(1):110-119. PubMed ID: 31605793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis.
    Chen S; Bao Y; Xu J; Zhang X; He S; Zhang Z; Qi R; Jiang J; Liu R; Guo Q; Zhang X; Xi Y; Zheng H; Hua B
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2913-2935. PubMed ID: 32797283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Niraparib as Maintenance Treatment in Patients With Extensive-Stage SCLC After First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study.
    Ai X; Pan Y; Shi J; Yang N; Liu C; Zhou J; Zhang X; Dong X; He J; Li X; Chen G; Li X; Zhang H; Liao W; Zhang Y; Ma Z; Jiang L; Cui J; Hu C; Wang W; Huang C; Zhao J; Ding C; Hu X; Wang K; Gao B; Song Y; Liu X; Xiong J; Liu A; Li J; Liu Z; Li Y; Wang M; Zhang B; Zhang D; Lu S
    J Thorac Oncol; 2021 Aug; 16(8):1403-1414. PubMed ID: 33915252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706).
    Zhang Z; Luo F; Zhang Y; Ma Y; Hong S; Yang Y; Fang W; Huang Y; Zhang L; Zhao H
    Cancer Commun (Lond); 2019 Nov; 39(1):69. PubMed ID: 31699150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
    Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
    Trials; 2015 Apr; 16():146. PubMed ID: 25873045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
    Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
    Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.